HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Loss of function of Slc20a2 associated with familial idiopathic Basal Ganglia calcification in humans causes brain calcifications in mice.

Abstract
Familial idiopathic basal ganglia calcification (FIBGC) is a neurodegenerative disorder with neuropsychiatric and motor symptoms. Deleterious mutations in SLC20A2, encoding the type III sodium-dependent phosphate transporter 2 (PiT2), were recently linked to FIBGC in almost 50% of the families reported worldwide. Here, we show that knockout of Slc20a2 in mice causes calcifications in the thalamus, basal ganglia, and cortex, demonstrating that reduced PiT2 expression alone can cause brain calcifications.
AuthorsNina Jensen, Henrik Daa Schrøder, Eva Kildall Hejbøl, Ernst-Martin Füchtbauer, João Ricardo Mendes de Oliveira, Lene Pedersen
JournalJournal of molecular neuroscience : MN (J Mol Neurosci) Vol. 51 Issue 3 Pg. 994-9 (Nov 2013) ISSN: 1559-1166 [Electronic] United States
PMID23934451 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Slc20a2 protein, mouse
  • Sodium-Phosphate Cotransporter Proteins, Type III
Topics
  • Animals
  • Basal Ganglia Diseases (genetics, metabolism, pathology)
  • Brain (pathology)
  • Calcinosis (genetics, metabolism, pathology)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Neurodegenerative Diseases (genetics, metabolism, pathology)
  • Sodium-Phosphate Cotransporter Proteins, Type III (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: